Prognostic Value of Histological Response to Chemotherapy in Osteosarcoma Patients Receiving Tumor-Bearing Frozen Autograft

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Miwa, Shinji ^a   Takeuchi, Akihiko ^a   Ikeda, Hiroko ^b   Shirai, Toshiharu ^a   Yamamoto, Norio ^a   Nishida, Hideji ^a   Hayashi, Katsuhiro ^a   Tanzawa, Yoshikazu ^a   Kimura, Hiroaki ^a   Igarashi, Kentaro ^a   Tsuchiya, Hiroyuki ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ARTICLE; BONE GRAFT; BONE REMODELING; CANCER CHEMOTHERAPY; CHILD; DRUG RESPONSE; EXCISION; FEMALE; FROZEN TUMOR BEARING AUTOGRAFT; HISTOLOGICAL RESPONSE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; PRESCHOOL CHILD; PROGNOSIS; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; AUTOGRAFTS; BONE NEOPLASMS; BONE TRANSPLANTATION; CHILD, PRESCHOOL; CRYOPRESERVATION; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84881601026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071362     Document Type: Article

References (40)

1. Chen WM, Chen TH, Huang CK, Lin CF, Shih LY, et al. (2000) Treatment of high-grade primary osteosarcoma in extremities: 15-year clinical experience in VGH-Taipei. J Orthop Surg 17: 11-16.
2. Chen WM, Chen TH, Huang CK, Chiang CC, Lo WH, (2002) Treatment of malignant bone tumours by extracorporeally irradiated autograft-prosthetic composite arthoplasty. J Bone Joint Surg Br 84: 1156-1161.
3. Chen WM, Wu PK, Chen CF, Chung LH, Liu CL, et al. (2012) High-grade osteosarcoma treated with hemicortical resection and biological reconstruction. J Surg Oncol 105: 825-829.
4. Grimer RJ, (2005) Surgical options for children with osteosarcoma. Lancet Oncol 6: 85-92.
5. Tsuchiya H, Tomita K, Minematsu K, Mori Y, Asada N, et al. (1997) Limb salvage using distraction osteogenesis. A classification of the technique. J Bone Joint Surg Br 79: 403-411.
6. Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N, (1999) Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 358: 27-35.
7. Tsuchiya H, Wan SL, Sakayama K, Yamamoto N, Nishida H, et al. (2005) Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg Br 87: 218-225.
8. Tsuchiya H, Nishida H, Srisawat P, Shirai T, Hayashi K, et al. (2010) Pedicle frozen autograft reconstruction in malignant bone tumors. J Orthop Sci 15: 340-349.
9. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, et al. (1982) Preoperative chemotherapy for osteogenic osteosarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221-1230.
10. Enneking WF, Spanier SS, Goodman MA, (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153: 106-120.
11. Tsuboyama T, Toguchida J, Kotoura Y, Kasahara K, Hiraoka M, et al. (2000) Intra-operative radiation therapy for osteosarcoma in the extremities. Int Orthop 24: 202-207.
12. Manabe J, Ahmed AR, Kawaguchi N, Matsumoto S, Kuroda H, (2004) Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419: 258-266.
13. Lauritzen C, Alberius P, Santanelli F, Vällfors B, Lilja J, et al. (1991) Repositioning of craniofacial tumorous bone after autoclaving. Scand J Plast Reconstr Surg Hand Surg 25: 161-165.
14. Ehara S, Nishida J, Shiraishi H, Tamakawa Y, (2000) Pasteurized intercalary autogenous bone graft: radiographic and scintigrahic features. Skeletal Radiol 29: 335-339.
15. Takata M, Sugimoto N, Yamamoto N, Shirai T, Hayashi K, et al. (2011) Activity of bone morphogenetic protein-7 after treatment at various temperatures: freezing vs. pasteurization vs. allograft. Cryobiology 63: 235-239.
16. Nishida H, Tsuchiya H, Tomita K, (2008) Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma. J Bone Joint Surg Br 90: 1249-1255.
17. Tanzawa Y, Tsuchiya H, Shirai T, Hayashi K, Yo Z, et al. (2009) Histological examination of frozen autograft treated by liquid nitrogen removed after implantation. J Orthop Sci 14: 761-768.
18. Tanzawa Y, Tsuchiya H, Yamamoto N, Sakayama K, Minato H, et al. (2008) Histological examination of frozen autograft treated by liquid nitrogen removed 6 years after implantation. J Orthop Sci 13: 259-264.
19. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, et al. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776-790.
20. Davis AM, Bell RS, Goodwin PJ, (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12: 423-431.
21. Furukawa T, Kubota T, Hoffman RM, (1995) Clinical applications of the histoculture drug response assay. Clin Cancer Res 1: 305-311.
22. Hoffman RM (2010) Histocultures and Their Use. Encyclopedia of Life Sciences. John Wiley and Sons, Ltd.: Chichester.
23. Kubota T, Sasano N, Abe O, Nakano I, Kawamura E, et al. (1995) Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res 1: 1537-1543.
24. Vescio RA, Redfern CH, Nelson TJ, (1987) In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci USA 84: 5029-5033.
25. Freeman AE, Hoffman RM, (1986) In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83: 2694-2698.
26. Miwa S, Shirai T, Taki J, Sumiya H, Nishida H, et al. (2011) Use of 99mTc-MIBI scintigraphy in the Evaluation of the Response to Chemotherapy for Osteosarcoma: Comparison with 201Tl scintigraphy and angiography. Int J Clin Oncol 16: 373-378.
27. Miwa S, Taki J, Yamamoto N, Shirai T, Nishida H, et al. (2012) A novel combined radiological method for evaluation of the response to chemotherapy for primary bone sarcoma. J Surg Oncol 106: 273-279.
28. Miwa S, Takeuchi A, Shirai T, Taki J, Yamamoto N,et al. (in press) Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. PLoS ONE (in press).
29. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, et al. (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106: 1154-1161.
30. Ferrari S, Bacci G, Picci P, Mercuri M, Briccoli A, et al. (1997) Long-term follow-up and post-relapse survival in patients with nonmetastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 8: 765-771.
31. Ford S, Saithna A, Grimer RJ, Picci P, (2004) Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centres. Sarcoma 8: 13-18.
32. Pakos EE, Nearchou AD, Grimer RJ, Koumoullis HD, Abudu A, et al. (2009) Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer 45: 2367-2375.
33. Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, et al. (2003) Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 97: 3068-3075.
34. Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, et al. (2005) Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer 41: 2079-2085.
35. Li X, Ashana AO, Moretti VM, Lackman RD, (2011) The relation of tumour necrosis and survival in patients with osteosarcoma. Int Orthop 35: 1847-1853.
36. Harting MT, Lally KP, Andrassy RJ, Vaporciyan AA, Cox CS Jr, et al. (2010) Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients. J Cancer Res Clin Oncol 136: 561-570.
37. Bacci G, Briccoli A, Ferrari S, Longhi A, Mercuri M, et al. (2001) Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer 37: 2030-2039.
38. Le Deley MC, Guinebretière JM, Gentet JC, Pacquement H, Pichon F, et al. (2007) SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer 43: 752-761.
39. Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, et al. (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 99: 112-128.
40. Bielack SS, Machatschek JN, Flege S, Jurgens H, (2004) Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother 5: 1243-1256.